BR112015010908A2 - derivado de pirrol sulfonamida, método de preparação para o mesmo e aplicação médica do mesmo - Google Patents

derivado de pirrol sulfonamida, método de preparação para o mesmo e aplicação médica do mesmo

Info

Publication number
BR112015010908A2
BR112015010908A2 BR112015010908A BR112015010908A BR112015010908A2 BR 112015010908 A2 BR112015010908 A2 BR 112015010908A2 BR 112015010908 A BR112015010908 A BR 112015010908A BR 112015010908 A BR112015010908 A BR 112015010908A BR 112015010908 A2 BR112015010908 A2 BR 112015010908A2
Authority
BR
Brazil
Prior art keywords
pyrrol
preparation
medical application
sulfonamide derivative
derivative
Prior art date
Application number
BR112015010908A
Other languages
English (en)
Inventor
Lan Jiong
Chen Lei
Sun Piaoyang
Dong Qing
Peng Wei
Liu Xing
Original Assignee
Jiangsu Hansoh Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Hansoh Pharmaceutical Co Ltd filed Critical Jiangsu Hansoh Pharmaceutical Co Ltd
Publication of BR112015010908A2 publication Critical patent/BR112015010908A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Epidemiology (AREA)

Abstract

resumo patente de invenção: "derivado de pirrol sulfonamida, método de preparação para o mesmo e aplicação médica do mesmo". a presente invenção refere-se a um derivado de pirrol sulfonamida, um método para a preparação do mesmo, e uma aplicação médica do mesmo. especificamente, a presente invenção se refere a um novo derivado de pirrol sulfonamida como representado pela fórmula (i), um método para a preparação do derivado, uma composição farmacêutica que compreende o derivado, e o uso do mesmo como agentes terapêuticos, e especificamente como um inibidor da secreção gástrica ácida e bloqueadores ácidos competitivo com potássio (os p-cab), em que cada substituinte da fórmula (i) está definido na descrição.
BR112015010908A 2012-11-19 2013-11-06 derivado de pirrol sulfonamida, método de preparação para o mesmo e aplicação médica do mesmo BR112015010908A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201210468283 2012-11-19
PCT/CN2013/086628 WO2014075575A1 (zh) 2012-11-19 2013-11-06 吡咯磺酰类衍生物、其制备方法及其在医药上的应用

Publications (1)

Publication Number Publication Date
BR112015010908A2 true BR112015010908A2 (pt) 2017-07-11

Family

ID=50730585

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015010908A BR112015010908A2 (pt) 2012-11-19 2013-11-06 derivado de pirrol sulfonamida, método de preparação para o mesmo e aplicação médica do mesmo

Country Status (12)

Country Link
US (1) US9388133B2 (pt)
EP (1) EP2921479B1 (pt)
JP (1) JP6292736B2 (pt)
KR (1) KR20150084974A (pt)
CN (1) CN104718189B (pt)
AU (1) AU2013347383B2 (pt)
BR (1) BR112015010908A2 (pt)
CA (1) CA2891523A1 (pt)
RU (1) RU2015122126A (pt)
TW (1) TW201420565A (pt)
WO (1) WO2014075575A1 (pt)
ZA (1) ZA201503753B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105367550A (zh) * 2014-08-11 2016-03-02 江苏柯菲平医药股份有限公司 四氢环戊二烯并[c]吡咯类衍生物、其制备方法及其在医药上的应用
CN104447491B (zh) * 2014-11-19 2017-06-23 连云港恒运医药有限公司 含吡咯环质子泵抑制剂的半富马酸盐及其中间体和医药用途
WO2016078594A1 (zh) * 2014-11-19 2016-05-26 江苏豪森药业集团有限公司 含吡咯环质子泵抑制剂的半富马酸盐及其晶型、中间体和医药用途
CN104447490B (zh) * 2014-11-19 2017-06-06 连云港恒运医药有限公司 一种质子泵抑制剂的晶型、制备中间体及其合成方法和医药用途
CN105985278A (zh) * 2015-01-27 2016-10-05 江苏柯菲平医药股份有限公司 吡咯磺酰类衍生物、其制备方法及其在医药上的应用
KR101613245B1 (ko) 2015-04-27 2016-04-18 주식회사 대웅제약 신규의 4-메톡시 피롤 유도체 또는 이의 염 및 이를 포함하는 약학 조성물
CN106432191A (zh) * 2015-08-10 2017-02-22 陕西合成药业股份有限公司 一种新的吡咯类衍生物、其制备方法及其在医药上的应用
CN105085484B (zh) * 2015-08-21 2017-11-24 南京济群医药科技股份有限公司 一种富马酸沃诺拉赞的制备方法
KR102081920B1 (ko) 2016-03-25 2020-02-26 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형
WO2017164575A1 (en) * 2016-03-25 2017-09-28 Daewoong Pharmaceutical Co.,Ltd. Novel acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3- fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n- methylmethanamine
KR20170113040A (ko) 2016-03-25 2017-10-12 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민의 신규한 산부가염
CN108191830B (zh) * 2016-06-30 2019-06-14 珠海赛隆药业股份有限公司（长沙）医药研发中心 一种富马酸沃诺拉赞中间体ⅳ及其制备方法
CN115385845A (zh) * 2016-09-12 2022-11-25 江苏柯菲平医药股份有限公司 一种吡咯磺酸类化合物盐型制备
CN107879964B (zh) * 2016-09-29 2023-02-10 江苏柯菲平医药股份有限公司 1-(5-(2-氟苯基)-1-(3-(3-甲氧丙氧基)苯磺酰氯)-1h-吡咯-3-基)-n-甲基胺的制备方法
CN108069891B (zh) * 2016-11-16 2022-09-20 江苏柯菲平医药股份有限公司 一类甲基甲胺盐酸盐的a晶型、制备及其应用
CN108117503B (zh) * 2016-11-30 2022-09-02 江苏柯菲平医药股份有限公司 吡咯磺酰类新化学实体、制备方法及其用途
KR102233456B1 (ko) * 2017-05-31 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
CN108969520A (zh) * 2017-06-02 2018-12-11 南京柯菲平盛辉制药有限公司 一种n-甲基甲胺盐酸盐的a晶型化合物的组合物
KR102126576B1 (ko) * 2018-09-19 2020-06-24 주식회사 대웅제약 4-메톡시 피롤 유도체의 제조 방법
CN111620804A (zh) * 2020-06-17 2020-09-04 山东理工大学 两种磺酰基吡咯烷P-CABs的合成方法及用途
CN116239606A (zh) * 2021-07-09 2023-06-09 天地恒一制药股份有限公司 一种吡咯磺酰类衍生物、及其制备方法与应用
CN115594623A (zh) * 2021-07-09 2023-01-13 天地恒一制药股份有限公司（Cn） 一种吡咯磺酰类衍生物、及其制备方法与应用
CN113620930B (zh) * 2021-07-12 2022-08-16 南京烁慧医药科技有限公司 一种含磺酰胺结构的化合物及其制备方法和应用、一种药物组合物及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201551B (en) 1988-02-03 1990-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 4-oxo-4h-pyrido(1,2-a)pyrimidine-3-carboxylic acid amide derivatives and pharmaceutical compositions comprising same
EP1105387B1 (en) * 1998-08-10 2003-01-29 Winston Pharmateuticals LLC Prodrugs of proton pump inhibitors
CN101361738A (zh) 2003-11-03 2009-02-11 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物
JP5173192B2 (ja) * 2004-09-30 2013-03-27 武田薬品工業株式会社 プロトンポンプ阻害薬
US7718809B2 (en) 2005-06-14 2010-05-18 Raqualia Pharma Inc. Chromane substituted benzimidazole derivatives as acid pump antagonists
RS52473B9 (sr) * 2005-08-30 2019-07-31 Takeda Pharmaceuticals Co 1-heterociklilsulfonil, 2-aminometil, 5-(hetero-)aril supstituisani derivati 1-h-pirola kao inhibitori sekrecije kiseline
US8933105B2 (en) * 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
KR101559597B1 (ko) 2007-09-28 2015-10-12 다케다 야쿠힌 고교 가부시키가이샤 ５―원 헤테로시클릭 화합물
WO2010021149A1 (ja) 2008-08-21 2010-02-25 武田薬品工業株式会社 酸分泌抑制スピロ化合物
US7999135B2 (en) * 2009-07-21 2011-08-16 Ge Healthcare As Crystallization of iodixanol using ultrasound
CN101962388B (zh) 2010-10-14 2012-12-19 天津药物研究院 乙酰胺衍生物及其制备方法和用途

Also Published As

Publication number Publication date
WO2014075575A1 (zh) 2014-05-22
KR20150084974A (ko) 2015-07-22
JP6292736B2 (ja) 2018-03-14
CN104718189A (zh) 2015-06-17
EP2921479B1 (en) 2017-02-01
RU2015122126A (ru) 2017-01-10
AU2013347383B2 (en) 2017-04-06
ZA201503753B (en) 2016-08-31
JP2015537011A (ja) 2015-12-24
TW201420565A (zh) 2014-06-01
EP2921479A4 (en) 2016-05-25
CN104718189B (zh) 2017-03-15
US20150307449A1 (en) 2015-10-29
EP2921479A1 (en) 2015-09-23
US9388133B2 (en) 2016-07-12
AU2013347383A1 (en) 2015-05-28
CA2891523A1 (en) 2014-05-22

Similar Documents

Publication Publication Date Title
BR112015010908A2 (pt) derivado de pirrol sulfonamida, método de preparação para o mesmo e aplicação médica do mesmo
BR112016000909A8 (pt) derivados piperidinil indólicos, seus usos, e combinação e composição farmacêuticas
BR112014014184A2 (pt) triazolopiridinas substituídas e seu uso como inibidores de ttk
BR112013021537A2 (pt) derivados de tiazolilpenil-benzenosulfonamido como inibidores da quinase
BR112014000713A2 (pt) derivados de indol substituído como moduladores de gama secretase
BR112014015363A8 (pt) derivados de ácido alfa-amino borônico, inibidores de imunoproteassoma seletivos
BR112014018879A8 (pt) Composto e composição farmacêutica e combinação compreendendo dito composto
DOP2013000239A (es) Derivados de ácido 3-fenilpropiónico ramificados y su uso.
BR112015000578A2 (pt) moduladores da via do complemento e usos dos mesmos
BR112013023517A2 (pt) "inibidores de produção de leucotrieno, seus usos, e composição farmacêutica"
ECSP14006132A (es) Derivados de ácido benzotiazol-6-il acético y su uso para tratar una infección por vih
CO7240369A2 (es) Ácido 5-aminotetrahidroquinolin-2-carboxílicos novedosos y su uso
UY32174A (es) Nuevos heterociclos sustituidos, composiciones farmaceuticas conteniendolos, procedimientos de preparacion y aplicaciones
ECSP12012334A (es) Morfolinopirimidinas y su uso en terapia
BR112014013661A8 (pt) derivados de nucleosídeos 2’,4’-difluoro-2’-metil substituídos como inibidores de replicação de hcv-rna
BR112013000254A2 (pt) derivados heterocíclicos 1-fenil-substituídos e seu uso como moduladores do receptor de prostaglandina d2
BR112013031268A2 (pt) "polipeptídeos análogos de pramlintida, uso dos mesmos, composição farmacêutica compreendendo os referidos polipeptídeos e método de preparação da referida composição".
UY32848A (es) Compuestos heterocíclicos de oxima
EA201390198A1 (ru) Гетероциклическое соединение
BR112013000059A2 (pt) derivados de piperidina e seus usos para o tratamento de distúrbios metabólicos
BR112015007647A2 (pt) derivados de quetamina
NZ607580A (en) N-heteroaryl compounds
BR112014031091A2 (pt) Derivados de piperidina para agonista de gpr119
BR112013026361A2 (pt) derivados de glicosídeo e usos dos mesmos
BR112015031878A2 (pt) composição farmacêutica

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B06I Technical and formal requirements: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 5A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2487 DE 04-09-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.